Omnicell

$153.01 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Omnicell

Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is engaged in the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems and related software. The Medication Adherence segment includes the development, manufacturing and selling of consumable medication blister cards, packaging equipment, medication synchronization platform, and ancillary products and services. Its products are used to manage medication administration outside of the hospital setting and include medication adherence products sold under the brand name MTS, Surgichem, SureMed and the Omnicell brand.

Stock Analysis

last close $149.19
1-mo return -0.4%
3-mo return 6.3%
avg daily vol. 229.16T
52-week high 154.92
52-week low 66.04
market cap. $6.3B
forward pe 38.8
annual div. -
roe 6.2%
ltg forecast 15%
dividend yield -
annual rev. $987M
inst own. -
baraka

Subscribe now for daily local and international financial news

Subscribe